0000950170-24-034198.txt : 20240320 0000950170-24-034198.hdr.sgml : 20240320 20240320162811 ACCESSION NUMBER: 0000950170-24-034198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240319 FILED AS OF DATE: 20240320 DATE AS OF CHANGE: 20240320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GKCC, LLC CENTRAL INDEX KEY: 0001977769 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 24768131 BUSINESS ADDRESS: STREET 1: 501 SILVERSIDE ROAD STREET 2: SUITE 87AVA CITY: WILMINGTON STATE: DE ZIP: 19809 BUSINESS PHONE: (302) 992-8882 MAIL ADDRESS: STREET 1: 501 SILVERSIDE ROAD STREET 2: SUITE 87AVA CITY: WILMINGTON STATE: DE ZIP: 19809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chudnovsky Yekaterina CENTRAL INDEX KEY: 0001979324 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39990 FILM NUMBER: 24768132 MAIL ADDRESS: STREET 1: C/O ELICIO THERAPEUTICS, INC. STREET 2: 451 D STREET, 5TH FLOOR, SUITE 501 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elicio Therapeutics, Inc. CENTRAL INDEX KEY: 0001601485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 113430072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (857) 209-0050 MAIL ADDRESS: STREET 1: 451 D STREET, 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Angion Biomedica Corp. DATE OF NAME CHANGE: 20140228 4 1 ownership.xml 4 X0508 4 2024-03-19 0001601485 Elicio Therapeutics, Inc. ELTX 0001979324 Chudnovsky Yekaterina C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 true false true false 0001977769 GKCC, LLC 501 SILVERSIDE ROAD, SUITE 87AVA WILMINGTON DE 19809 false false true false false Pre-Funded Common Stock Purchase Warrant 0.01 2024-03-19 4 P false 1032702 5.81 A Common Stock 1032702 1032702 I Held by GKCC, LLC Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained. The Pre-Funded Warrants do not have an expiration date. Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. /s/ Yekaterina Chudnovsky 2024-03-20 /s/ Yekaterina Chudnovsky, Manager of GKCC, LLC 2024-03-20